Read + Share
Amedeo Smart
Independent Medical Education
Lu K, Shi Q, Gong YQ, Shao JW, et al. Predicting the acute-phase response fever risk in bisphosphonate-naive osteoporotic patients receiving their first dose of zoledronate. Osteoporos Int 2022 Aug 3. pii: 10.1007/s00198-022-06493.PMID: 35920895
Email
LinkedIn
Facebook
Twitter
Privacy Policy